3646 results for «519»
3646 results
China experience in TAVI evolution
22 May 2025 – From EuroPCR 2025
This session highlights key innovations and recent research from China in the field of transcatheter aortic valve implantation (TAVI). Leading cardiovascular specialist present new data on pacing strategies, comparing left bundle branch area pacing with traditional right ventricular pacing in TAVI patients. They also explore the use...
Impact of transcatheter mitral valve treatment on ventricular dimensions and functions
20 May 2025 – From EuroPCR 2025
Investigate the impact of transcatheter mitral valve therapies on ventricular dimensions and function. This session discusses invasive physiology changes, left and right ventricular remodeling post-TEER and TMVR, and geometric alterations of the mitral annulus, presenting data from multiple registries and studies.
Clinical implications of TAVI and cerebral embolic protection - Current challenges and future considerations
21 May 2025 – From EuroPCR 2025
Cerebral embolic protection (CEP) remains a key consideration in modern TAVI procedures, as stroke continues to be one of the most serious complications. This EuroPCR 2025 session takes a close look at the latest data on CEP use in clinical practice, weighing where it fits best...
Complex calcified lesions: combination of intravascular imaging and orbital atherectomy for optimal outcomes
20 May 2025 – From EuroPCR 2025
In this EuroPCR 2025 session on complex calcified coronary lesions, follow a step-by-step analysis of a recorded case structured in three key phases: lesion assessment with OCT, PCI using orbital atherectomy, and post-PCI optimisation with follow-up OCT imaging. Gain valuable insights into managing severely calcified lesions,...
Coronary sinus reducer for microvascular angina
28 Feb 2020
A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
